13F filer · CIK 1634557
Woodford Investment Management Ltd
London, X0 · filing since Q4 2014 · last filing Jan 27, 2020
Reported value
$0
$-310.1M vs prior
Positions
1
New / sold out
1 / 3
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $310.1M
Top-10 weight
–
Biggest buys vs Q3 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | N/A | 0 | – | – |
Biggest sells vs Q3 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | THERAVANCE BIOPHARMA INC | -11,350,719 | -100.0% | $-221.1M |
| Sold out | EVOFEM BIOSCIENCES INC | -12,496,222 | -100.0% | $-63.0M |
| Sold out | AUTOLUS THERAPEUTICS PLC | -2,095,127 | -100.0% | $-26.0M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2019
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | N/AN/A | 0 | $0 | – |